Promising Clinical Trial Results Drive Buy Rating for Bicara Therapeutics
In a report released yesterday, Judah Frommer from Morgan Stanley maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report), ...
Stifel Nicolaus Sticks to Their Buy Rating for Bicara Therapeutics Inc. (BCAX)
In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report).